AD
Aditya Birla Sun Life US Equity Passive FoF Direct Growth
Latest NAV
+18.22% 1Y
Sign In to Add to Portfolio
Benchmark: NASDAQ - 100 TRI
Expense ratio
0.34%
AUM
₹496 Cr
Min SIP
₹100
Min lump sum
₹100
1Y
+18.22%
3Y (ann.)
+27.55%
5Y (ann.)
+17.16%
Launched
Nov 2021
Where the NAV sits & how risky it is
₹20.84
52-week range
at 44%
₹20.84
Low 21 Nov 2025₹17.75
High 06 Oct 2026₹24.80
Risk level
Very High
Low
Very high
NAV history
08 Nov 2021
Since inception
19 Nov 2026
Returns by period
1W
-1.15%
1M
-10.62%
3M
-5.59%
6M
-4.63%
1Y
+18.22%
3Y
+27.55%
5Y
+17.16%
3Y and 5Y returns are annualised.
Return calculator
You invest
—
Est. gain
—
Est. value
—
Invested Gain
Invested
Projected value
Estimate only. It assumes the selected past return repeats every year; 3Y and 5Y figures are taken as annualised. Actual returns vary and are not guaranteed.
Where your money goes
AS OF 31 MAY 2026
This is a fund of funds — it invests in other funds and ETFs rather than individual companies, so the source publishes its underlying holdings without a sector split.
Underlying fund
| # | Fund / ETF | Weight | YTD |
|---|---|---|---|
| 1 | iShares NASDAQ 100 ETF USD Acc
IE00B53SZB19 |
99.19%
|
+0.00% |
About this scheme
The investment objective of the scheme is to provide long-term capital appreciation by investing in units of overseas ETFs and/or Index Fund based on NASDAQ-100 Index.
Fund manager(s): Mehul Dama, Priya Sridhar
Exit load: No charges for withdrawal
Scheme snapshot
VR Rating
MS Rating
Plan
Growth
Type
DIRECT
Inception
01 Nov 2021
Lump-sum min
₹100
SIP
Purchase
Switch
STP
SWP
Similar schemes
RANKED BY 1Y RETURN
ICICI Prudential Strategic Metal and Energy Equity FoF Direct Growth
1▲ 25.1 pts ahead of this fund
Mirae Asset NYSE FANG+ ETF FoF Direct Growth
2▲ 19.2 pts ahead of this fund
Mirae Asset S&P 500 Top 50 ETF FoF Direct Growth
3▲ 18.6 pts ahead of this fund
DSP World Mining Overseas Equity Omni FoF Direct Growth
4▲ 12.0 pts ahead of this fund
Edelweiss US Value Equity Offshore Fund Direct Growth
5▲ 9.3 pts ahead of this fund
ICICI Prudential Nifty Pharma Index Fund Direct Growth
6▲ 8.8 pts ahead of this fund